Derivative Instruments And Hedging Activities (Tables)

3 Months Ended

Mar. 31, 2018

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of balance sheet location and fair value of derivative instruments designated as hedging instruments

The following table presents the balance sheet location and fair value of our derivative instruments that were designated as hedging instruments (in thousands): 

	March 31, 2018			December 31, 2017
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Asset Derivative Instruments:
Interest rate swaps	Other current assets	$	670	Other current assets	$	311
Interest rate swaps	Other assets, net	832		Other assets, net	655
		$	1,502		$	966
Liability Derivative Instruments:
Foreign exchange contracts	Accrued liabilities	$	6,396	Accrued liabilities	$	7,492
Foreign exchange contracts	Other non-current liabilities	2,827		Other non-current liabilities	4,975
		$	9,223		$	12,467

Schedule of balance sheet location and fair value of derivative instruments not designated as hedging instruments

The following table presents the balance sheet location and fair value of our derivative instruments that were not designated as hedging instruments (in thousands): 

	March 31, 2018			December 31, 2017
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Liability Derivative Instruments:
Foreign exchange contracts	Accrued liabilities	$	2,661	Accrued liabilities	$	3,133
Foreign exchange contracts	Other non-current liabilities	2,113		Other non-current liabilities	3,175
		$	4,774		$	6,308

Schedule of unrealized gain recognized in OCI

The following tables present the impact that derivative instruments designated as hedging instruments had on our Accumulated OCI (net of tax) and our condensed consolidated statements of operations (in thousands). We estimate that as of March 31, 2018, $4.6 million of losses in Accumulated OCI associated with our derivative instruments is expected to be reclassified into earnings within the next 12 months.

	Unrealized Gain Recognized in OCI (Effective Portion)
	Three Months Ended March 31,
	2018		2017
Foreign exchange contracts	$	1,588	$	671
Interest rate swaps	565		238
	$	2,153	$	909

Schedule of gain (loss) reclassified from Accumulated OCI into earnings

	Location of Gain (Loss) Reclassified from Accumulated OCI into Earnings	Gain (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)
		Three Months Ended March 31,
		2018			2017
Foreign exchange contracts	Cost of sales	$	(1,656	)	$	(3,221	)
Interest rate swaps	Net interest expense	29			(269		)
		$	(1,627	)	$	(3,490	)

Schedule of impact of derivative instruments not designated as hedging instruments on consolidated statements of operations

The following table presents the impact that derivative instruments not designated as hedging instruments had on our condensed consolidated statements of operations (in thousands): 

	Location of Gain Recognized in Earnings	Gain Recognized in Earnings
		Three Months Ended March 31,
		2018		2017
Foreign exchange contracts	Other income (expense), net	$	844	$	52
		$	844	$	52